Literature DB >> 17336686

The pathology of lupus nephritis.

Melvin M Schwartz1.   

Abstract

An international working group of clinicians and pathologists met in 2003 under the auspices of the International Society of Nephrology (ISN) and the Renal Pathology Society (RPS) to revise and update the 1982 and 1995 World Health Organization classification of lupus glomerulonephritis. This article compares and contrasts the ISN/RPS classification and the antecedent World Health Organization classifications. Although systemic lupus erythematosus is the prototypical systemic immune-complex disease, several non-immune-complex mechanisms of glomerular injury and dysfunction have been proposed, and this article summarizes the evidence supporting the pathogenic mechanisms of lupus vasculitis, glomerular capillary thrombosis, and lupus podocytopathy. The most significant and controversial feature of the ISN/RPS classification is the separation of diffuse glomerulonephritis into separate classes with either segmental (class IV-S) or global (class IV-G) lesions. Several groups have tested the prognostic significance of this separation, and this article discusses the implications of these studies for the ISN/RPS classification.

Entities:  

Mesh:

Year:  2007        PMID: 17336686     DOI: 10.1016/j.semnephrol.2006.09.005

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  12 in total

Review 1.  Histopathology of lupus nephritis.

Authors:  Konstantinos Giannakakis; Tullio Faraggiana
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

Review 2.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

3.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  J Data Mining Genomics Proteomics       Date:  2012-03-27

4.  Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis.

Authors:  Xue Zhao; Jun Hao; Huijun Duan; Zanhua Rong; Fan Li
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 5.  Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians.

Authors:  Hitoshi Yokoyama; Hiroshi Okuyama; Hideki Yamaya
Journal:  Clin Exp Nephrol       Date:  2011-03-25       Impact factor: 2.801

Review 6.  Nanotechnology applications in rheumatology.

Authors:  Arvind Nune; Bhupen Barman; Hem R Sapkota; Pranav Ish; Easwaradhas G Chelliah; Masroor Diwan; Apam Chiphang; Karthikeyan P Iyengar
Journal:  Rheumatol Int       Date:  2022-05-19       Impact factor: 3.580

Review 7.  CD11b agonists offer a novel approach for treating lupus nephritis.

Authors:  Veronica Villanueva; Xiaobo Li; Viviana Jimenez; Hafeez M Faridi; Vineet Gupta
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

Review 8.  Lupus nephritis: lessons from murine models.

Authors:  Anne Davidson; Cynthia Aranow
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

Review 9.  What is damaging the kidney in lupus nephritis?

Authors:  Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2015-11-19       Impact factor: 20.543

10.  Vitamin D receptor gene BsmI polymorphisms in Egyptian children and adolescents with systemic lupus erythematosus: A case-control study.

Authors:  Seham F Azab; Yasser F Ali; Mohsen A A Farghaly; Mohammed E Hamed; Mayy A N Allah; Ahmed A Emam; Nasser I Abdelsalam; Mustafa I A Hashem; Heba H Gawish; Rehab M Nabil; Lamiaa M Kamel; Dalia S Fahmy; Salah F Alsayed; Nashwa M Al Azizi; Ghada M Al-Akad; Maha A Noah; Hind M Abdelrahman; Ahmed R Ahmed; Eman A Bendary
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.